Singh AK, Bhushan B, Maurya A, Mishra G, Singh SK, Awasthi R. Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders. Dermatol Ther. 2020;33:e13591.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rai SN, Tiwari N, Singh P, Singh AK, Mishra D, Imran M, Singh S, Hooshmandi E, Vamanu E, Singh SK, Singh MP. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease. Oxid Med Cell Longev 2022, 2022:3012778.

V’Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155–70.

Article  PubMed  Google Scholar 

Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol. 2021;21:475–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh AK, Maurya A, Mishra G, Awasthi R, Dua K, Kulkarni GT. Nanovaccine: a hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19). Recent Pat Nanotechnol. 2023;17:15–7.

PubMed  Google Scholar 

Wang S, Qiu Z, Hou Y, Deng X, Xu W, Zheng T, Wu P, Xie S, Bian W, Zhang C, et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 2021;31:126–40.

Article  CAS  PubMed  Google Scholar 

Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clausen TM, Sandoval DR, Spliid CB, Pihl J, Perrett HR, Painter CD, Narayanan A, Majowicz SA, Kwong EM, McVicar RN, et al. SARS-CoV-2 infection depends on Cellular Heparan Sulfate and ACE2. Cell. 2020;183:1043–e10571015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bohan D, Van Ert H, Ruggio N, Rogers KJ, Badreddine M, Aguilar Briseno JA, Elliff JM, Rojas Chavez RA, Gao B, Stokowy T, et al. Phosphatidylserine receptors enhance SARS-CoV-2 infection. PLoS Pathog. 2021;17:e1009743.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, Polacco BJ, Melnyk JE, Ulferts S, Kaake RM, et al. The Global Phosphorylation Landscape of SARS-CoV-2 infection. Cell. 2020;182:685–e712619.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holland SJ, Pan A, Franci C, Hu Y, Chang B, Li W, Duan M, Torneros A, Yu J, Heckrodt TJ, et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 2010;70:1544–54.

Article  CAS  PubMed  Google Scholar 

Sheridan C. First Axl inhibitor enters clinical trials. Nat Biotechnol. 2013;31:775–6.

Article  CAS  PubMed  Google Scholar 

Rayson D, Lupichuk S, Potvin K, Dent S, Shenkier T, Dhesy-Thind S, Ellard SL, Prady C, Salim M, Farmer P, et al. Canadian Cancer trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer. Breast Cancer Res Treat. 2016;157:109–16.

Article  CAS  PubMed  Google Scholar 

Yau TCC, Lencioni R, Sukeepaisarnjaroen W, Chao Y, Yen CJ, Lausoontornsiri W, Chen PJ, Sanpajit T, Camp A, Cox DS, et al. A phase I/II Multicenter Study of single-Agent Foretinib as First-Line therapy in patients with Advanced Hepatocellular Carcinoma. Clin Cancer Res. 2017;23:2405–13.

Article  CAS  PubMed  Google Scholar 

Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008;585:325–37.

Article  CAS  PubMed  Google Scholar 

Huang K-Y, Wang T-H, Chen C-C, Leu Y-L, Li H-J, Jhong C-L, Chen C-Y. Growth suppression in Lung Cancer cells harboring EGFR-C797S mutation by Quercetin. Biomolecules. 2021;11:1271.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukherjee A, Khuda-Bukhsh AR. Quercetin Down-regulates IL-6/STAT-3 signals to induce mitochondrial-mediated apoptosis in a nonsmall- cell lung-cancer cell line, A549. J Pharmacopunct. 2015;18:19–26.

Article  Google Scholar 

Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Reyburn HT, Rizzuti B, Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol. 2020;164:1693–703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhowmik D, Nandi R, Prakash A, Kumar D. Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. Heliyon. 2021;7:e06515.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, et al. Possible therapeutic effects of Adjuvant Quercetin Supplementation against early-stage COVID-19 infection: a prospective, randomized, controlled, and open-label study. Int J Gen Med. 2021;14:2359–66.

Article  PubMed  PubMed Central  Google Scholar 

Han Q, Wang X, Cai S, Liu X, Zhang Y, Yang L, Wang C, Yang R. Quercetin nanoparticles with enhanced bioavailability as multifunctional agents toward amyloid induced neurotoxicity. J Mater Chem B. 2018;6:1387–93.

Article  CAS  PubMed  Google Scholar 

Zhao MH, Yuan L, Meng LY, Qiu JL, Wang CB. Quercetin-loaded mixed micelles exhibit enhanced cytotoxic efficacy in non-small cell lung cancer in vitro. Exp Ther Med. 2017;14:5503–8.

CAS  PubMed  PubMed Central  Google Scholar 

Lee KH, Yoo CG. Simultaneous inactivation of GSK-3beta suppresses quercetin-induced apoptosis by inhibiting the JNK pathway. Am J Physiol Lung Cell Mol Physiol. 2013;304:L782–789.

Article  CAS  PubMed  Google Scholar 

Lee Y-J, Song J-H, Oh M-H, Lee Y-J, Kim Y-B, Im J-H, Lee S-H. ERK1/2 activation in quercetin-treated BEAS-2B cell plays a role in Nrf2-driven HO-1 expression. Mol Cell Toxicol. 2011;7:347–55.

Article  CAS  Google Scholar 

Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, Yu F. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther. 2021;6:233.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101–24.

Article  CAS  PubMed  Google Scholar 

Chen CK, Huang PK, Law WC, Chu CH, Chen NT, Lo LW. Biodegradable polymers for gene-delivery applications. Int J Nanomed. 2020;15:2131–50.

Article  CAS  Google Scholar 

Singh AK, Singh SS, Rathore AS, Singh SP, Mishra G, Awasthi R, Mishra SK, Gautam V, Singh SK. Lipid-coated MCM-41 mesoporous silica nanoparticles loaded with Berberine Improved Inhibition of Acetylcholine Esterase and amyloid formation. ACS Biomater Sci Eng. 2021;7:3737–53.

Article  CAS  PubMed  Google Scholar 

Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomed (Lond). 2016;11:673–92.

Article  CAS  Google Scholar 

Zhao Z, Chen C, Wu W, Wang F, Du L, Zhang X, Xiong Y, He X, Cai Y, Kwok RTK, et al. Highly efficient photothermal nanoagent achieved by harvesting energy via excited-state intramolecular motion within nanoparticles. Nat Commun. 2019;10:768.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prutskij T, Deriabina A, Melendez FJ, Castro ME, Castillo Trejo L, Vazquez Leon GD, Gonzalez E, Perova TS. Concentration-dependent fluorescence Emission of Quercetin. Chemosensors. 2021;9:315.

Article  CAS  Google Scholar 

Holzer M, Vogel V, Mantele W, Schwartz D, Haase W, Langer K. Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage. Eur J Pharm Biopharm. 2009;72:428–37.

Article  CAS  PubMed  Google Scholar 

Scalia S, Haghi M, Losi V, Trotta V, Young PM, Traini D. Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery. Eur J Pharm Sci. 2013;49:278–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taniguchi H, Yamada T, Wang R, Tanimura K, Adachi Y, Nishiyama A, Tanimoto A, Takeuchi S, Araujo LH, Boroni M, et al. AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells. Nat Commun. 2019;10:259.

Article  PubMed  PubMed Central  Google Scholar 

Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, de Meulder D, van Amerongen G, van den Brand J, Okba NMA, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020;368:1012–5.

Article  CAS  PubMed  PubMed Central